Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Evercore ISI Group Initiates Coverage On Legend Biotech with Outperform Rating

Evercore ISI Group analyst Umer Raffat initiates coverage on Legend Biotech (NASDAQ:LEGN) with a Outperform rating.

byBenzinga Newsdesk

November 2, 2022

1 minute read

Evercore ISI Group analyst Umer Raffat initiates coverage on Legend Biotech (NASDAQ:LEGN) with a Outperform rating.

Here’s How Much You Would Have Made Owning AbbVie Stock In The Last 5 Years

By Benzinga Insights

Today, 4:53 AM

AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 5.85% on an annualized basis.

ABBV

Piper Sandler Assumes Wolverine World Wide at Overweight, Announces Price Target of $30

By Benzinga Newsdesk

Today, 4:53 AM

Piper Sandler analyst Abbie Zvejnieks assumes Wolverine World Wide (NYSE:WWW) with a Overweight rating and announces Price Target of $30.

WWW

Analyst Ratings

Analyst Ratings For Plains All American

By Benzinga Insights

Today, 4:53 AM

Plains All American (NASDAQ:PAA) has observed the following analyst ratings within the last quarter: Last 30 Days 1 Month Ago 2 Months Ago

PAA

Media
News

Here’s The New Acronym From Jim Cramer Replacing FAANG

By Chris Katje

Today, 4:53 AM

In a highly anticipated move, Facebook, Inc. (NASDAQ: FB) announced its new name and a new stock symbol Thursday at its Facebook Connect event. The new stock ticker and name could change one of the most well-known investing acronyms of big tech stocks.

AAPL

Evercore ISI Group Initiates Coverage On Legend Biotech with Outperform Rating

Related Posts

Here’s How Much You Would Have Made Owning AbbVie Stock In The Last 5 Years

Piper Sandler Assumes Wolverine World Wide at Overweight, Announces Price Target of $30

Analyst Ratings For Plains All American

Here’s The New Acronym From Jim Cramer Replacing FAANG